Episode

Ep190: Neil Kumar on Building a Rare Disease Drug Company

Podcast: The Long Run with Luke Timmerman
Published: Nov 20, 2025
Duration seconds: 4392
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep190-neil-kumar-on-building-a-rare-disease-drug-company
Audio: https://feeds.soundcloud.com/stream/2215845644-longrunpodcast-ep190-neil-kumar-on-building-a-rare-disease-drug-company.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep190-neil-kumar-on-building-a-rare-disease-drug-company
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep190-neil-kumar-on-building-a-rare-disease-drug-company.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep190-neil-kumar-on-building-a-rare-disease-drug-company/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep190-neil-kumar-on-building-a-rare-disease-drug-company.md
Read the agent-friendly Markdown representation of this episode resource.

Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.